Emergex Vaccines expands at Milton Park
Emergex Vaccines, which focuses on the development of synthetic T-cell vaccines against global infectious disease threats such as COVID-19, Dengue fever, Zika, Ebola and pandemic Flu, has expanded at Milton Park in Oxfordshire, one of Europe’s largest science and...
£4.6 billion in new lockdown grants to support businesses and protect jobs
Chancellor announces one-off top up grants for retail, hospitality and leisure businesses worth up to £9,000 per property to help businesses through to the Spring£594 million discretionary fund also made available to support other impacted businessescomes in addition...
Gearing for Growth: Transitioning to York Biotech Campus in the midst of a global pandemic
Liz Cashon, Innovation Campus Manager at York Biotech Campus COVID-19 has, without a doubt, changed the face of bioscience for the long term. Already vital research facilities became centres of focus overnight as the world looked to scientific research teams to find...
Inventive use of space allows Diagnostics for the Real World to keep on top of demand for COVID-19 test kits
Chesterford Research Park based Diagnostics for the Real World (DRW) made worldwide headlines earlier this year with a game-changing way of testing for COVID-19. The University of Cambridge spinout responded quickly to the pandemic by adapting its HIV testing machine,...
